AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-29151562_ITM" title="Facts and information about Pfizer, Teva to compete with generic Zoloft.(Business)(Brief article)">Pfizer, Teva to compete with generic Zoloft.(Business)(Brief article)</a>
Close
Set up an RSS feed that alerts you when new articles from Mental Health Weekly are available.
Frequently asked questions about RSS feeds
Pfizer, Teva to compete with generic Zoloft.(Business)(Brief article)
The end of June marked the expiration of drug maker Pfizer's patent for its antidepressant drug Zoloft (sertraline), which accounted for over $3 billion in worldwide sales in 2005. Pfizer's subsidiary Greenstone Ltd. has announced it will release an "authorized generic" version of the drug "if and when others release" their own generic versions. …
Related articles from newspapers, magazines, journals, and more
-
- Ranbaxy gets generic Zoloft approval.
-
News wire article from: Europe Intelligence Wire
February 8, 2007
700+ words
-
- Barr launches generic Zoloft.
-
News wire article from: Europe Intelligence Wire
February 6, 2007
700+ words
-
- Teva launches first generic Zoloft.
-
News wire article from: Europe Intelligence Wire
August 14, 2006
700+ words
-
- Mylan gets FDA nod on generic Zoloft.
-
News wire article from: Europe Intelligence Wire
February 6, 2007
700+ words
